Company PURE Bioscience, Inc. Other OTC
Equities
PURE
US74621T2096
Household Products
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pure Hard Surface
95.2
%
| 1 | 80.8 % | 2 | 95.2 % | +19.23% |
Silverion
4.5
%
| 0 | 17.0 % | 0 | 4.5 % | -73.02% |
Royalty
0.3
%
| 0 | 2.2 % | 0 | 0.3 % | -85.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +1.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 07/02/23 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 31/12/03 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/97 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 08/05/11 |
Tom Lee
BRD | Director/Board Member | 75 | 23/10/14 |
John Kasperski
SAM | Sales & Marketing | - | 31/03/22 |
Zhinong Yan
PRN | Corporate Officer/Principal | - | 30/04/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 07/02/23 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 08/05/11 |
Tom Lee
BRD | Director/Board Member | 75 | 23/10/14 |
Ivan Chen
CHM | Chairman | 41 | 27/06/18 |
David Rendall
BRD | Director/Board Member | 51 | 26/01/21 |
Bernard Blotner
BRD | Director/Board Member | 73 | 07/02/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 111,856,473 | 66,608,527 ( 59.55 %) | 0 | 59.55 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-17.42% | 39.57B | |
+12.21% | 25.95B | |
-26.35% | 6.18B | |
+6.07% | 5.98B | |
-3.79% | 3.12B | |
+7.64% | 2.55B | |
-12.34% | 1.86B | |
+25.31% | 954M | |
-3.28% | 642M |